Justin Parkinson, MD
Urology · Bountiful, UTNPI 1851314066
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,311 of the $5,117 with a category attached, or 64.7%. 10 manufacturers reported payments, led by Medtronic at 53.5% of the total. 2025 is the largest year on record at $1,553, 4.2 times the $368 reported in 2019.
Across 64 payments — averaging $79.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Valencia Technologies Corporation$1K
- Boston Scientific$816
- Ferring Pharmaceuticals Inc.$112
- Bayer$57
- Teleflex LLC$36
- plus $69 from 4 others
What the payments were for
- Travel & lodging$3,31165%
- Food & beverage$1,79735%
- Education$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 25 | $2,739 |
| Valencia Technologies Corporation | 2 | $1,290 |
| Boston Scientific | 27 | $816 |
| Ferring Pharmaceuticals Inc. | 1 | $112 |
| Bayer | 1 | $57 |
| Teleflex LLC | 2 | $36 |
| Travere Therapeutics, Inc. | 3 | $31 |
| Axonics, Inc. | 1 | $19 |
| Urovant Sciences Inc | 1 | $13 |
| Clarus Therapeutics Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- eCoin Device Kit$1,208
- ALTAVIVA$1,053
- INTERSTIM$999
- LithoVue$213
- NOCDURNA$112
How this compares
$5,117 in reported general payments places this provider in the 60th percentile of 96 urology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 28 | $22,267 |
| MyrbetriqMirabegron | 30 | $20,401 |
| Methenamine Hippurate | 56 | $6,427 |
| Solifenacin Succinate | 119 | $5,767 |
| Tamsulosin Hcl | 252 | $4,309 |
| Estradiol | 41 | $2,345 |
| Testosterone Cypionate | 30 | $1,348 |
| Cefdinir | 82 | $1,338 |
| Desmopressin Acetate | 15 | $628 |
| Oxybutynin Chloride ErOxybutynin Chloride | 22 | $444 |
| Finasteride | 27 | $354 |
| Cephalexin | 27 | $226 |
| Doxycycline Hyclate | 14 | $148 |
| Oxybutynin Chloride | 24 | $138 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $132 |
Paid to pharmacies, not to this prescriber.
Other urology in Bountiful
- Brian MontgomeryBountiful$6K
- Steven GangeSlc$1.5M
- William BrantSalt Lake City$290K
- Roscoe NelsonAmerican Fork$152K
- Nathan PursifullAmerican Fork$86K
- Benjamin McCormickSalt Lake City$67K
- Richard MaternSalt Lake City$58K
- Akhil SajiSalt Lake City$49K
- Jeffrey SparenborgProvo$37K
- Daniel SimonRiverton$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.